PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis
10-Oct-2024 New Study Demonstrates Scalp Cooling Efficacy in Reducing Persistent Chemotherapy-Induced Alopecia Paxman
10-Oct-2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer FluoGuide A/S
10-Oct-2024 Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public GWI research
10-Oct-2024 Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer Curve Therapeutics
10-Oct-2024 Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 Antag Therapeutics
10-Oct-2024 PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting PureTech Health plc
10-Oct-2024 Purespring Therapeutics raises £80 million in a Series B financing Syncona Ltd
10-Oct-2024 Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer Driven by EGFR Exon 19 or 21 and Co-occurring C797S Mutations Pierre Fabre Laboratories
10-Oct-2024 ACG Accelerates European Growth with Major Expansion in Croatia ACG
10-Oct-2024 Mestag Therapeutics Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases Mestag Therapeutics
10-Oct-2024 Elafibranor approved as first medicine to treat adults with a rare liver disease known as primary biliary cholangitis MHRA
10-Oct-2024 Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute Veranova
09-Oct-2024 The Future of Clinical Research Education: Trends and Courses Fusion Technology Solutions
09-Oct-2024 Preliminary Data of BellaSeno’s Clinical Trial on Scaffold-Guided Breast Regeneration Presented at the 93rd Annual Plastic Surgery Meeting in San Diego, CA BellaSeno GmbH
08-Oct-2024 Adcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma (STS) Adcendo
08-Oct-2024 EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office EVERSANA
08-Oct-2024 MONCYTE Health Raises EUR 1 Million Seed Capital to Advance Personalized Treatment for High Cholesterol MONCYTE Health
07-Oct-2024 ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ViiV Healthcare